Vivesto AB

OM:VIVE Stock Report

Market Cap: SEK 151.2m

Vivesto Management

Management criteria checks 2/4

We currently do not have sufficient information about the CEO.

Key information

Erik Kinnman

Chief executive officer

SEK 4.8m

Total compensation

CEO salary percentage54.3%
CEO tenure1.9yrs
CEO ownershipn/a
Management average tenure3.2yrs
Board average tenure5.4yrs

Recent management updates

Recent updates

Will Vivesto (STO:VIVE) Spend Its Cash Wisely?

Apr 25
Will Vivesto (STO:VIVE) Spend Its Cash Wisely?

Will Vivesto (STO:VIVE) Spend Its Cash Wisely?

Aug 21
Will Vivesto (STO:VIVE) Spend Its Cash Wisely?

CEO Compensation Analysis

How has Erik Kinnman's remuneration changed compared to Vivesto's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

-SEK 93m

Jun 30 2024n/an/a

-SEK 99m

Mar 31 2024n/an/a

-SEK 117m

Dec 31 2023SEK 5mSEK 3m

-SEK 129m

Compensation vs Market: Erik's total compensation ($USD436.30K) is above average for companies of similar size in the Swedish market ($USD232.20K).

Compensation vs Earnings: Insufficient data to compare Erik's compensation with company performance.

CEO

Erik Kinnman (66 yo)

1.9yrs

Tenure

SEK 4,811,000

Compensation

Mr. Erik Kinnman, M.D., Ph D., M.B.A., Assoc. Prof., serves as Chief Executive Officer at Vivesto AB since January 23, 2023.He had been Chief Executive Officer at Sprint Bioscience AB (publ) since March 1...

Leadership Team

NamePositionTenureCompensationOwnership
Erik Kinnman
Chief Executive Officer1.9yrsSEK 4.81mno data
Robert Maiorana
Head of Accounting & Acting CFO2.4yrsno data0.0037%
SEK 5.6k
Urban Ekelund
IR Managerno datano datano data
John Cosby
Head of Regulatory Affairs18.9yrsno datano data
Dzianis Babrou
Head of Product Developmentno datano datano data
Henrik Rönnberg
Chief Medical Officer of Animal Health9.3yrsno datano data
Maria Hagberg
Head of Regulatory Affairs5.7yrsno datano data
Heidi Ramstad
Chief Medical Officer1.9yrsno datano data
Johanna Rostin
Chief Regulatory Officer3.2yrsno datano data
Kia Bengtsson
Head of Clinical Development3.2yrsno datano data
Teresa Zafra
Head of Preclinical Development & Clinical Operationsless than a yearno datano data

3.2yrs

Average Tenure

57yo

Average Age

Experienced Management: VIVE's management team is considered experienced (3.2 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Göran Pettersson
Chairman of Business Advisory Board5.4yrsno datano data
Hans Grönlund
Member of Scientific Advisory Board5.4yrsno datano data
Mohammed Homman
Member of Business Advisory Board5.4yrsno datano data
Jacob Kaluski
Member of Business Advisory Board5.4yrsno datano data
Rolf Lewensohn
Chairman of Scientific Advisory Board5.4yrsno datano data
Kerstin Strinnholm
Member of Business Advisory Board5.5yrsno datano data
Pal Ryfors
Independent Director2.6yrsSEK 427.00kno data
Hege Hellstrom
Member of Business Advisory Board & Independent Director5.4yrsSEK 361.00kno data
Roger Tell
Independent Director2.6yrsSEK 361.00kno data
Ola Winqvist
Member of Scientific Advisory Board5.4yrsno datano data
Peter Zonabend
Chairman of the Board5.8yrsSEK 756.00k0.13%
SEK 202.3k

5.4yrs

Average Tenure

59yo

Average Age

Experienced Board: VIVE's board of directors are considered experienced (5.4 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/22 13:58
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Vivesto AB is covered by 6 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Camilla OxhamreCarnegie Investment Bank AB
Susie JanaEdison Investment Research
Sean ConroyEdison Investment Research